"TidalHealth Nanticoke is an award-winning non-profit community hospital providing comprehensive care for our community. Part of TidalHealth, bringing quality care to our friends and neighbors across Delmarva."

During the past decade, Nanticoke Memorial Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 38 clinical trials were completed, i.e. on average, 140.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 31 clinical trials were completed. i.e. 3100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nanticoke Memorial Hospital" #1 sponsor was "SWOG Cancer Research Network" with 21 trials, followed by "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored, "National Cancer Institute (NCI)" with 6 trials sponsored and "Gynecologic Oncology Group" with 6 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nanticoke Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 51 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Nanticoke Memorial Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (5 trials), "Stage IIIA Breast Cancer" (4 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Nanticoke Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Nanticoke Memorial Hospital" are "Drug" (48 trials), "Other" (35 trials), "Biological" (14 trials), "Procedure" (7 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Quality-of-Life Assessment" (10 trials), "Docetaxel" (7 trials), "placebo" (6 trials) and "Questionnaire Administration" (5 trials). Other intervention names were less common.

The vast majority of trials in "Nanticoke Memorial Hospital" are 46 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Nanticoke Memorial Hospital". undefined are not yet recruiting, 1 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Nanticoke Memorial Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Nanticoke Memorial Hospital, 3 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Nanticoke Memorial Hospital has several departments that took part in Clinical trials: "TidalHealth Nanticoke / Allen Cancer Center" - 101 trials, "TidalHealth Richard A Henson Cancer Institute" - 19 trials